Procardia‑XL–Adalat‑LA

Procardia‑XL and Adalat‑LA are both extended‑release formulations of nifedipine, a calcium channel blocker used in the management of hypertension and angina. These medications work by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle cells, leading to vasodilation and a reduction in blood pressure. The extended‑release formulations provide a more consistent plasma level throughout the day, which helps maintain steady blood pressure control and reduce the risk of angina episodes.

The mechanism of action centers on the relaxation of arterial smooth muscle, which lowers systemic vascular resistance. This reduction in afterload decreases the workload on the heart and improves oxygen delivery to cardiac tissue, thereby alleviating symptoms of angina. By prolonging the release of nifedipine, these formulations help avoid the rapid blood pressure fluctuations that can sometimes occur with immediate‑release preparations.

Procardia‑XL and Adalat‑LA are typically taken once daily, making them convenient options for patients who require long‑term blood pressure management. The once‑daily dosing regimen can improve adherence to therapy and enhance overall cardiovascular outcomes. Healthcare providers adjust the dose based on individual blood pressure responses and tolerance, ensuring that patients receive the optimal balance between efficacy and safety.

While these medications are generally well tolerated, common side effects can include headache, peripheral edema, and dizziness. Because nifedipine can cause vasodilation, some patients may experience flushing or reflex tachycardia. It is important for patients to follow up regularly with their healthcare provider to monitor blood pressure and adjust the dose as necessary to minimize side effects.

In summary, Procardia‑XL and Adalat‑LA offer effective and convenient management for patients with hypertension and angina. Their extended‑release delivery system helps maintain stable blood levels of nifedipine, promoting consistent blood pressure control while reducing the frequency of anginal episodes. With individualized dosing and careful monitoring, these medications can play a vital role in reducing cardiovascular risk and improving quality of life.


NOTE: The above information is for marketing purposes only and is not to be construed as medical advice. Seek advice for medications from a qualified physician.

We are not currently selling this medicine.